Analyst Report: SLB Ltd

Celldex Therapeutics, Inc. (CLDX) Discusses Positive Phase 3 Results for Barzolvolimab in Chronic Spontaneous Urticaria Transcript

Elastic N.V. (ESTC) Discusses New Metrics Offering and Observability Platform Enhancements Transcript

UBS: The Decline Is Not Surprising To Me Given Regulation Updates

Abbott: Quality Remains, But Exact Sciences Has Raised The Bar For Buy

Trump administration removes around 760,000 Obamacare enrollments, alleging fraud